drugset / Trial / NCT02921386

The Effect of Various Amounts of Fat on PK of Oral Testosterone Undecanoate

NCT02921386

Phase 2 Completed 18 enrolled Clarus Therapeutics, Inc. Celerion · collab
Non-randomizedCrossoverOpen-labelBasic science

Summary

A Phase 2, open-label, randomized, cross-over, pharmacokinetic study designed to determine the effect of meals of various amounts of fat given immediately prior to dosing on the pharmacokinetics of oral testosterone undecanoate. Approximately 20 hypogonadal subjects will be dosed for a 14 day run-in period. This will be followed by a randomized sequence of five periods over a 6 day confinement period. Subjects will receive a randomly ordered sequence of breakfast meals containing various amounts of fat, fasting, 15 g, 30 g, 45 g and a high fat breakfast consistent Guidance for Industry on Food-Effect Bioavailability and Fed Bioequivalence Studies.

Timeline

Start
2016-10
Primary completion
2017-01-21
Completion
2017-01-21

Drugs

EvaluationDrugModalityDoseRoute
Subject Testosterone Undecanoate Small molecule 237 mg Oral

Indications